CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $85.58 ($427,923)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 8,000 shares at an average $83.66 ($669,267)
- 144 Insider Sale of Securities
- 4 Planned sale PRESIDENT AND CFO sold 8,000 shares at an average $88.78 ($710,249)
- 4 Option exercise SVP, FINANCE acquired 7,716 shares (option exercise)
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 2,500 shares (grant or award)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 2,366 shares at an average $92.25 ($218,253)
- 4 Planned sale SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $91.49 ($457,434)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $92.45 ($1,386,794)
- 4 Planned sale CHIEF OPERATING OFFICER sold 8,000 shares at an average $92.49 ($739,885)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Other events
- 4 Planned sale PRESIDENT AND CFO sold 8,000 shares at an average $85.81 ($686,518)
- 4 Insider Changes in Ownership
- 144 Insider Sale of Securities
Page 11 of 39 · 770 filings